Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BB can you share an example where settlement occurred after an appeal loss ? Thanks in advance.
Wow, wouldn’t that be something ...
Thanks as always marjac
Marjac,
Out of curiosity how is a petition for en banc examined and decided? Are appeal briefs actually read? Because it seems clear they were not by the 3 appellate judges. Does anyone listen to appeal OA’s before deciding whether to grant or reject en banc review? I mean in our case it would only be taking 21 minutes out of someone’s day. This whole process seems entirely lazy and careless.
Your efforts are appreciated
All the more reason Vascepa belongs in Pfizer’s hands!!!!!!
If what is being discussed here about a “joint venture” comes to fruition, wouldn’t it now make more sense than ever for Amrn to sell the company holistically? BP would obviously pave the way to a more optimal market for generics than AMRN would. This would also allow Amrn to salvage some value out of the US.
Now is there a way for this to be structured into some sort of marketing deal between BP and generics. While I understand this can be construed as a pay to delay, this obviously benefits both parties, is this illegal ?
I think what he meant was generics will intentionally hold out a few more years to allow us to build market for them... but I probably shouldn’t be speaking for someone who is infinitely smarter than I
Would you mind being a decent person and sharing how you’re so sure ?
I sent this to john.thero@amarincorp.com
I received this from someone else and i’m not sure it’s 100% accurate.
Just sent to Thero...
Good morning John,
It has been a never ending battle for Amarin, and for the retail investor on the outside looking in, there is no real end in sight.
My father has been an avid investor for the better part of a decade, i’ve joined in on the fun in the past 5 years. Elisabeth has hinted towards the fact that you guys happen to scour the forums such as ihub and stocktwits for insight and retail investor sentiment, so I’m sure you know by now the frustration runs wild over the past few months.
I’m not in the “I hate Amarin Management” fan club, but that doesn’t matter because do you know who seems to be, John? The FDA, Big Pharma, Wall Street, and the US Legal System. We have been competing in a game in the US that we could not win, John.
I’ve heard the spiel about maximizing shareholder value in damn near every conference call since i jumped on board, John. Please do not tell me you truthfully believe we’ll see $26 or more again one day. While investing always comes with risks, as an outsider it seems like this debacle could have been avoided.
I’m not blaming you for this next topic, as nobody should ever invest what they can’t afford to lose but think about the people who jumped in after 9/24/18, John. Or worse, after 12/13/19. The way this all played out has destroyed retirements and lifestyles.
The moral of my story is simple. Nobody wants to watch Amarin attempt to build this brand on their own in Europe. This company needs to be sold immediately to the highest bidder. Whether that’s $8, $10,$15,$20 at this point, we will happily accept.
I wish you all the best, John. Please act sensibly and responsibly. Big Pharma will distribute this drug to the masses in the ROW and at least they will benefit.
Tucaman, we appreciate your efforts and I can’t argue with you for not wanting to watch how this disaster plays out. Be well.
I agree. I just don’t know what the barriers to bring a combo pill to market would be. I’m sure it would be alot easier for BP to overcome such barriers. I try to remain level-headed, but I cannot see this being the end all be all for branded Vascepa in the US market. There has to be a viable back up that has not been publicized, but it most certainly requires an acquisition of AMRN.
What happened to a combo pill idea ? Can BP not acquire AMRN and formulate a Vascepa/Statin combo in US ?
I was under the impression this can not happen due to the side effects. Not sure if i am correct
Thanks north
Safe to assume OA’s actually being held were out of respect for Singer’s reputation?
This smells so fishy.
Affirmed.
Marjac or someone with legal experience,
Have you ever heard an appeal where one side is asked zero questions ?
Thank you
Marjac,
I recall a few months back someone stated Singer may have clerked for one or two of the CAFC judges. Do you know if that’s accurate? And if so, which one(s) ?
Well said
Worst case scenario, if this is affirmed 3-0, should we expect a decision very soon ?
Thank you so much. Worked!
Awesome thanks
I remember reading somewhere that Singer opens up with roughly 13 minutes of arguing, generics argue for 15 and then Singer gets to wrap it up with a couple more minutes. Is that accurate???
If Singer presents anything like the 2nd attorney in the 1st case i’m pounding the sell button on Wednesday.
That last paragraph really gets the blood pumping!!
Thank you for sharing
I’m in!
Correct
You are a legend
Thank you.
Sorry, i was misunderstanding the original tweet and I did not have a subscription to the link that was posted. From what I gather, Dyk was reversed by the federal circuit on a decision he made at a lower court.
Anybody see this?
Federal Circuit reverses one its *own judges* (Dyk) sitting by designation in a patent case on claim construction. 🔥🔥🔥 https://t.co/UaXKoKTC5R
— Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) (@jsherkow) August 28, 2020
Thank you again for your help.
Marjac can you please share your opinion on the PACER update from today ?
What does this mean?
10 AM
And just like Du showed us, hindsight is 20/20. Best of luck to us all. We need it.